Simon Scrace

814 total citations
13 papers, 540 citations indexed

About

Simon Scrace is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Simon Scrace has authored 13 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Simon Scrace's work include DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Simon Scrace is often cited by papers focused on DNA Repair Mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers) and Ubiquitin and proteasome pathways (3 papers). Simon Scrace collaborates with scholars based in United Kingdom, Australia and Netherlands. Simon Scrace's co-authors include Eric O’Neill, Karen S. Yee, Nikola Vlahov, Daniela Paňková, Garth Hamilton, Anna M. Grawenda, Dafni‐Eleftheria Pefani, Aswin Abraham, Lisa Baker and Jonathan D. Moore and has published in prestigious journals such as The EMBO Journal, Molecular Cell and Cancer Research.

In The Last Decade

Simon Scrace

13 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Scrace United Kingdom	11	402	198	162	74	47	13	540
Ana Ruiz-Sáenz United States	14	266 0.7×	110 0.6×	157 1.0×	71 1.0×	48 1.0×	20	483
Shankar Varadarajan United Kingdom	16	467 1.2×	106 0.5×	131 0.8×	75 1.0×	66 1.4×	24	619
Anna-Kathrine Pedersen Denmark	9	532 1.3×	123 0.6×	120 0.7×	43 0.6×	72 1.5×	13	669
Matthew Ling-Hon Chu United States	11	567 1.4×	241 1.2×	177 1.1×	54 0.7×	19 0.4×	12	722
Armelle Calipel France	11	391 1.0×	85 0.4×	136 0.8×	68 0.9×	42 0.9×	12	559
Takeshi Jimbo Japan	11	398 1.0×	221 1.1×	179 1.1×	49 0.7×	36 0.8×	17	604
Nah-Young Shin United States	8	372 0.9×	243 1.2×	117 0.7×	34 0.5×	58 1.2×	9	591
Sirlester A. Parker United States	9	546 1.4×	177 0.9×	111 0.7×	91 1.2×	27 0.6×	9	664
Jasminka Omerović United Kingdom	10	410 1.0×	116 0.6×	183 1.1×	52 0.7×	62 1.3×	11	553
Yoshimi Endo Greer United States	15	474 1.2×	90 0.5×	171 1.1×	63 0.9×	152 3.2×	26	621

Countries citing papers authored by Simon Scrace

Since Specialization

Citations

This map shows the geographic impact of Simon Scrace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Scrace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Scrace more than expected).

Fields of papers citing papers by Simon Scrace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Scrace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Scrace. The network helps show where Simon Scrace may publish in the future.

Co-authorship network of co-authors of Simon Scrace

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Scrace. A scholar is included among the top collaborators of Simon Scrace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Scrace. Simon Scrace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Vlahov, Nikola, Sander Christiaan Steenbeek, Anna M. Grawenda, et al.. (2021). RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis. The EMBO Journal. 40(20). e107680–e107680. 13 indexed citations

Mason, Helen, Simon Scrace, Philippa Smith, et al.. (2017). Abstract 5160: Development of REDX05358, a novel highly selective and potent pan RAF inhibitor and a potential therapeutic for BRAF and RAS mutant tumors. Cancer Research. 77(13_Supplement). 5160–5160. 3 indexed citations

Pefani, Dafni‐Eleftheria, Daniela Paňková, Aswin Abraham, et al.. (2016). TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation. Molecular Cell. 63(1). 156–166. 117 indexed citations

Soto, Manuel Sarmiento, Simon Scrace, Rasheed Zakaria, et al.. (2016). Disruption of tumour-host communication by downregulation of LFA-1 reduces COX-2 and e-NOS expression and inhibits brain metastasis growth. Oncotarget. 7(32). 52375–52391. 20 indexed citations

Vlahov, Nikola, Simon Scrace, Manuel Sarmiento Soto, et al.. (2015). Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion. Current Biology. 25(23). 3019–3034. 63 indexed citations

Massey, Andrew J., S.P. Stokes, Helen Browne, et al.. (2015). Identification of novel,in vivoactive Chk1 inhibitors utilizing structure guided drug design. Oncotarget. 6(34). 35797–35812. 34 indexed citations

Scrace, Simon, Eric O’Neill, Ester M. Hammond, & Isabel M. Pires. (2013). Use of the xCELLigence System for Real-Time Analysis of Changes in Cellular Motility and Adhesion in Physiological Conditions. Methods in molecular biology. 1046. 295–306. 33 indexed citations

Scrace, Simon & Eric O’Neill. (2012). RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?. PubMed. 2012. 1–11. 13 indexed citations

Potter, Andrew, Christophe Fromont, Stuart Ray, et al.. (2010). Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. Bioorganic & Medicinal Chemistry Letters. 20(22). 6483–6488. 69 indexed citations

10.

Potter, Andrew, Stuart Ray, Chris Bryant, et al.. (2009). Structure-guided design of α-amino acid-derived Pin1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(2). 586–590. 73 indexed citations

11.

Hamilton, Garth, Karen S. Yee, Simon Scrace, & Eric O’Neill. (2009). ATM Regulates a RASSF1A-Dependent DNA Damage Response. Current Biology. 19(23). 2020–2025. 86 indexed citations

12.

Massey, Andrew J., S.P. Stokes, Helen Browne, et al.. (2009). Abstract C207: Checkpoint abrogation and potentiation of cytotoxic chemotherapeutics with a novel checkpoint kinase 1 inhibitor. Molecular Cancer Therapeutics. 8(12_Supplement). C207–C207. 1 indexed citations

13.

Scrace, Simon, Jenifer Borgognoni, Lan-Zhen Wang, et al.. (2008). Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked. Cell Cycle. 7(24). 3898–3907. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact